These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 25785995)

  • 41. Neutralization and hemagglutination-inhibition antibodies following influenza vaccination of HIV-infected and HIV-uninfected pregnant women.
    Nunes MC; Weinberg A; Cutland CL; Jones S; Wang D; Dighero-Kemp B; Levine MZ; Wairagkar N; Madhi SA
    PLoS One; 2018; 13(12):e0210124. PubMed ID: 30596775
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy.
    Pariani E; Boschini A; Amendola A; Poletti R; Anselmi G; Begnini M; Ranghiero A; Cecconi G; Zanetti AR
    Vaccine; 2011 Nov; 29(49):9209-13. PubMed ID: 21974995
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial.
    Forster AH; Witham K; Depelsenaire ACI; Veitch M; Wells JW; Wheatley A; Pryor M; Lickliter JD; Francis B; Rockman S; Bodle J; Treasure P; Hickling J; Fernando GJP
    PLoS Med; 2020 Mar; 17(3):e1003024. PubMed ID: 32181756
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduced immune response to influenza A (H1N1) 2009 monovalent vaccine in HIV-infected Japanese subjects.
    Yanagisawa N; Maeda K; Ajisawa A; Imamura A; Suganuma A; Ando M; Takayama N; Okuno Y
    Vaccine; 2011 Aug; 29(34):5694-8. PubMed ID: 21689709
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Abnormal humoral immune response to influenza vaccination in pediatric type-1 human immunodeficiency virus infected patients receiving highly active antiretroviral therapy.
    Montoya CJ; Toro MF; Aguirre C; Bustamante A; Hernandez M; Arango LP; Echeverry M; Arango AE; Prada MC; Alarcon Hdel P; Rojas M
    Mem Inst Oswaldo Cruz; 2007 Jun; 102(4):501-8. PubMed ID: 17612772
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Infection with 2009 H1N1 influenza virus primes for immunological memory in human nose-associated lymphoid tissue, offering cross-reactive immunity to H1N1 and avian H5N1 viruses.
    Mahallawi WH; Kasbekar AV; McCormick MS; Hoschler K; Temperton N; Leong SC; Beer H; Ferrara F; McNamara PS; Zhang Q
    J Virol; 2013 May; 87(10):5331-9. PubMed ID: 23468498
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety and immunogenicity of a monovalent MF59®-adjuvanted A/H1N1 vaccine in HIV-infected children and young adults.
    Palma P; Romiti ML; Bernardi S; Pontrelli G; Mora N; Santilli V; Tchidjou HK; Aquilani A; Cotugno N; Alghisi F; Lucidi V; Rossi P; Douagi I
    Biologicals; 2012 Mar; 40(2):134-9. PubMed ID: 22261282
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of immune response by virus infection and vaccination to 2009 pandemic influenza A/H1N1 in children.
    Kang EK; Lim JS; Lee JA; Kim DH
    J Korean Med Sci; 2013 Feb; 28(2):274-9. PubMed ID: 23399558
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunoglobulin G subclass levels and antibody responses to the 2009 influenza A (H1N1) monovalent vaccine among human immunodeficiency virus (HIV)-infected and HIV-uninfected adults.
    Crum-Cianflone NF; Collins G; Defang G; Iverson E; Eberly LE; Duplessis C; Maguire J; Ganesan A; Agan BK; Lalani T; Whitman T; Brandt C; Faix D; Blair PJ; Burgess T
    Clin Exp Immunol; 2012 Apr; 168(1):135-41. PubMed ID: 22385248
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection.
    Hakim H; Allison KJ; Van de Velde LA; Tang L; Sun Y; Flynn PM; McCullers JA
    Vaccine; 2016 Jun; 34(27):3141-3148. PubMed ID: 27129426
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Measuring antibody responses to a live attenuated influenza vaccine in children.
    Lee MS; Mahmood K; Adhikary L; August MJ; Cordova J; Cho I; Kemble G; Reisinger K; Walker RE; Mendelman PM
    Pediatr Infect Dis J; 2004 Sep; 23(9):852-6. PubMed ID: 15361726
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy.
    Weinberg A; Gona P; Nachman SA; Defechereux P; Yogev R; Hughes W; Wara D; Spector SA; Read J; Elgie C; Cooper M; Dankner W;
    J Infect Dis; 2006 Jan; 193(2):302-11. PubMed ID: 16362896
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Randomized Controlled Trial to Compare Immunogenicity to Cell-Based Versus Live-Attenuated Influenza Vaccines in Children.
    Williams KV; Li ZN; Zhai B; Alcorn JF; Nowalk MP; Levine MZ; Kim SS; Flannery B; Moehling Geffel K; Merranko AJ; Collins M; Susick M; Clarke KS; Zimmerman RK; Martin JM
    J Pediatric Infect Dis Soc; 2023 Jun; 12(6):342-352. PubMed ID: 37232430
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunogenicity of Licensed Influenza A (H1N1) 2009 Monovalent Vaccines in HIV-Infected Children and Youth.
    Pass RF; Nachman S; Flynn PM; Muresan P; Fenton T; Cunningham CK; Borkowsky W; McAuley JB; Spector SA; Petzold E; Levy W; Siberry GK; Handelsman E; Utech LJ; Weinberg A;
    J Pediatric Infect Dis Soc; 2013 Dec; 2(4):352-60. PubMed ID: 24363932
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dysfunctional peripheral T follicular helper cells dominate in people with impaired influenza vaccine responses: Results from the FLORAH study.
    Pallikkuth S; de Armas LR; Rinaldi S; George VK; Pan L; Arheart KL; Pahwa R; Pahwa S
    PLoS Biol; 2019 May; 17(5):e3000257. PubMed ID: 31100059
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Higher antigen content improves the immune response to 2009 H1N1 influenza vaccine in HIV-infected adults: a randomized clinical trial.
    El Sahly HM; Davis C; Kotloff K; Meier J; Winokur PL; Wald A; Johnston C; George SL; Brady RC; Lehmann C; Stokes-Riner A; Keitel WA
    J Infect Dis; 2012 Mar; 205(5):703-12. PubMed ID: 22275399
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
    J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of immunosenescence on humoral immune response variation after influenza A/H1N1 vaccination in older subjects.
    Haralambieva IH; Painter SD; Kennedy RB; Ovsyannikova IG; Lambert ND; Goergen KM; Oberg AL; Poland GA
    PLoS One; 2015; 10(3):e0122282. PubMed ID: 25816015
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Baseline Serum Vitamin A and D Levels Determine Benefit of Oral Vitamin A&D Supplements to Humoral Immune Responses Following Pediatric Influenza Vaccination.
    Patel N; Penkert RR; Jones BG; Sealy RE; Surman SL; Sun Y; Tang L; DeBeauchamp J; Webb A; Richardson J; Heine R; Dallas RH; Ross AC; Webby R; Hurwitz JL
    Viruses; 2019 Sep; 11(10):. PubMed ID: 31575021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.